ScholarIQanswers from OpenAlex

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19

PaperCitations, authors & open-access status

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 have?

ScholarIQcitation count

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 has 37 citations in the OpenAlex counts ScholarIQ stores.

When was Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 published?

ScholarIQyear

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 has 2022 year in the ScholarIQ index.

What is the open-access status of Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19?

ScholarIQoa status

Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 has gold oa status in the ScholarIQ index.

What is the DOI of Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19?

ScholarIQdoi

The DOI for Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 is on the source record.

What is the PMID of Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19?

ScholarIQpmid

The PMID for Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 is on the source record.

What is the OpenAlex record for Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19?

ScholarIQopenalex

The OpenAlex for Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial